Structure of the human Parkin ligase domain in an autoinhibited state

Mutations in the protein Parkin are associated with Parkinson's disease (PD), the second most common neurodegenerative disease in men. Parkin is an E3 ubiquitin (Ub) ligase of the structurally uncharacterized RING‐in‐between‐RING(IBR)‐RING (RBR) family, which, in an HECT‐like fashion, forms a catalytic thioester intermediate with Ub. We here report the crystal structure of human Parkin spanning the Unique Parkin domain (UPD, also annotated as RING0) and RBR domains, revealing a tightly packed structure with unanticipated domain interfaces. The UPD adopts a novel elongated Zn‐binding fold, while RING2 resembles an IBR domain. Two key interactions keep Parkin in an autoinhibited conformation. A linker that connects the IBR with the RING2 over a 50‐Å distance blocks the conserved E2∼Ub binding site of RING1. RING2 forms a hydrophobic interface with the UPD, burying the catalytic Cys431, which is part of a conserved catalytic triad. Opening of intra‐domain interfaces activates Parkin, and enables Ub‐based suicide probes to modify Cys431. The structure further reveals a putative phospho‐peptide docking site in the UPD, and explains many PD‐causing mutations.

[1]  E. Hirsch,et al.  The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. , 2003, Human molecular genetics.

[2]  K. Lim,et al.  Relative Sensitivity of Parkin and Other Cysteine-containing Enzymes to Stress-induced Solubility Alterations* , 2007, Journal of Biological Chemistry.

[3]  H. Walden,et al.  Autoregulation of Parkin activity through its ubiquitin‐like domain , 2011, The EMBO journal.

[4]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[5]  W. Chazin,et al.  Structure of an E3:E2~Ub complex reveals an allosteric mechanism shared among RING/U-box ligases. , 2012, Molecular cell.

[6]  Nathaniel Echols,et al.  The Phenix software for automated determination of macromolecular structures. , 2011, Methods.

[7]  Francis Barany,et al.  Fabrication of DNA microarrays onto polymer substrates using UV modification protocols with integration into microfluidic platforms for the sensing of low-abundant DNA point mutations. , 2005, Methods.

[8]  K. Lim,et al.  Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin. , 2005, Human molecular genetics.

[9]  I. Marín RBR Ubiquitin Ligases: Diversification and Streamlining in Animal Lineages , 2009, Journal of Molecular Evolution.

[10]  A. Whitworth,et al.  Drosophila Parkin requires PINK1 for mitochondrial translocation and ubiquitinates Mitofusin , 2010, Proceedings of the National Academy of Sciences.

[11]  R. Youle,et al.  Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism. , 2012, Cold Spring Harbor perspectives in biology.

[12]  N. Hattori,et al.  PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria , 2012, Nature Communications.

[13]  H. Ploegh,et al.  Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. , 2002, Chemistry & biology.

[14]  R. Youle,et al.  Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin , 2010, The Journal of cell biology.

[15]  R. Klevit,et al.  Following Ariadne's thread: a new perspective on RBR ubiquitin ligases , 2012, BMC Biology.

[16]  Wei Jiang,et al.  Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. , 2009, The Journal of clinical investigation.

[17]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[18]  M. Rapé,et al.  The Ubiquitin Code , 2012, Annual review of biochemistry.

[19]  Miratul M. K. Muqit,et al.  PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65 , 2012, Open Biology.

[20]  C. Culmsee,et al.  Parkin Mediates Neuroprotection through Activation of IκB Kinase/Nuclear Factor-κB Signaling , 2007, The Journal of Neuroscience.

[21]  Karen Marder,et al.  Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. , 2008, Archives of neurology.

[22]  H. Braak,et al.  100 years of Lewy pathology , 2013, Nature Reviews Neurology.

[23]  K. Winklhofer,et al.  Aberrant Folding of Pathogenic Parkin Mutants , 2008, Journal of Biological Chemistry.

[24]  A. Brice,et al.  Parkin occurs in a stable, non-covalent, ∼110-kDa complex in brain , 2008, The European journal of neuroscience.

[25]  K. Lim,et al.  Parkin Mediates Apparent E2-Independent Monoubiquitination In Vitro and Contains an Intrinsic Activity That Catalyzes Polyubiquitination , 2011, PloS one.

[26]  T. Sixma,et al.  The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extension , 2012, The EMBO journal.

[27]  N. Thakor,et al.  Parkin Facilitates the Elimination of Expanded Polyglutamine Proteins and Leads to Preservation of Proteasome Function* , 2003, Journal of Biological Chemistry.

[28]  J. Chin,et al.  Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains , 2011, Proceedings of the National Academy of Sciences.

[29]  Jin Man Kim,et al.  Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Sheldrick,et al.  Crystallographic ab initio protein structure solution below atomic resolution , 2009, Nature Methods.

[31]  Angela C. Poole,et al.  The Mitochondrial Fusion-Promoting Factor Mitofusin Is a Substrate of the PINK1/Parkin Pathway , 2010, PloS one.

[32]  David Alderton,et al.  A versatile ligation-independent cloning method suitable for high-throughput expression screening applications , 2007, Nucleic acids research.

[33]  A. Brice,et al.  Parkin protects dopaminergic neurons from excessive Wnt/beta-catenin signaling. , 2009, Biochemical and biophysical research communications.

[34]  W. Wurst,et al.  The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO. , 2013, Molecular cell.

[35]  Fabienne C. Fiesel,et al.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 , 2010, Nature Cell Biology.

[36]  K. Rittinger,et al.  LUBAC synthesizes linear ubiquitin chains via a thioester intermediate , 2012, EMBO reports.

[37]  David Komander,et al.  Breaking the chains: structure and function of the deubiquitinases , 2009, Nature Reviews Molecular Cell Biology.

[38]  D. Adams,et al.  PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice , 2010, Proceedings of the National Academy of Sciences.

[39]  Michael Lazarou,et al.  PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding , 2013, The Journal of cell biology.

[40]  V. Hristova,et al.  Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.

[41]  Kalle Gehring,et al.  Structure of Parkin Reveals Mechanisms for Ubiquitin Ligase Activation , 2013, Science.

[42]  Danny T. Huang,et al.  BIRC7–E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer , 2012, Nature Structural &Molecular Biology.

[43]  B. Dye,et al.  Structural mechanisms underlying posttranslational modification by ubiquitin-like proteins. , 2007, Annual review of biophysics and biomolecular structure.

[44]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[45]  A. Ferrús,et al.  Ariadne-1: a vital Drosophila gene is required in development and defines a new conserved family of ring-finger proteins. , 2000, Genetics.

[46]  Keiji Tanaka,et al.  A ubiquitin ligase complex assembles linear polyubiquitin chains , 2006, The EMBO journal.

[47]  H. Walden,et al.  Regulation of Parkin E3 ubiquitin ligase activity , 2012, Cellular and Molecular Life Sciences.

[48]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[49]  Ted M. Dawson,et al.  PINK1-dependent recruitment of Parkin to mitochondria in mitophagy , 2009, Proceedings of the National Academy of Sciences.

[50]  G. Dorn,et al.  PINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria , 2013, Science.

[51]  K. Lim,et al.  Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease‐linked point mutations , 2005, Journal of neurochemistry.

[52]  C. Sander,et al.  Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies , 2010, Nature Genetics.

[53]  F. Eisenhaber,et al.  The ring between ring fingers (RBR) protein family , 2007, Genome Biology.

[54]  N. Hattori,et al.  PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy , 2010, The Journal of cell biology.

[55]  M. Ruberg,et al.  The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates , 2003, Neurobiology of Disease.

[56]  C. Lima,et al.  Structural biology: A protein engagement RING , 2012, Nature.

[57]  A. Brice,et al.  Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity. , 2006, Human molecular genetics.

[58]  V. Hristova,et al.  Identification of a Novel Zn2+-binding Domain in the Autosomal Recessive Juvenile Parkinson-related E3 Ligase Parkin* , 2009, Journal of Biological Chemistry.

[59]  Sebastian A. Wagner,et al.  E3-independent monoubiquitination of ubiquitin-binding proteins. , 2007, Molecular cell.

[60]  Ping Wang,et al.  Structure of a c-Cbl–UbcH7 Complex RING Domain Function in Ubiquitin-Protein Ligases , 2000, Cell.

[61]  Atsushi Tanaka,et al.  PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin , 2010, PLoS biology.

[62]  R. Youle,et al.  Mechanisms of mitophagy , 2010, Nature Reviews Molecular Cell Biology.

[63]  T. Dawson,et al.  Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[64]  T. Gillis,et al.  Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. , 2006, Archives of neurology.

[65]  C. Culmsee,et al.  Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[66]  M. Scheffner,et al.  The Ubiquitin-conjugating Enzymes UbcH7 and UbcH8 Interact with RING Finger/IBR Motif-containing Domains of HHARI and H7-AP1* , 1999, The Journal of Biological Chemistry.

[67]  Kenneth Wu,et al.  Structure of the C-terminal RING finger from a RING-IBR-RING/TRIAD motif reveals a novel zinc-binding domain distinct from a RING. , 2004, Journal of molecular biology.

[68]  Rachel E. Klevit,et al.  UbcH7 reactivity profile reveals Parkin and HHARI to be RING/HECT hybrids , 2011, Nature.

[69]  N. Hattori,et al.  Diverse Effects of Pathogenic Mutations of Parkin That Catalyze Multiple Monoubiquitylation in Vitro* , 2006, Journal of Biological Chemistry.

[70]  A. Brice,et al.  What genetics tells us about the causes and mechanisms of Parkinson's disease. , 2011, Physiological reviews.

[71]  Michael P Robertson,et al.  The origins of the RNA world. , 2012, Cold Spring Harbor perspectives in biology.

[72]  Serge X. Cohen,et al.  Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7 , 2008, Nature Protocols.

[73]  James H. Naismith,et al.  Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis , 2012, Nature.

[74]  Xinnan Wang,et al.  PINK1 and Parkin Target Miro for Phosphorylation and Degradation to Arrest Mitochondrial Motility , 2011, Cell.

[75]  Steven P. Gygi,et al.  Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization , 2013, Nature.

[76]  Shinsei Minoshima,et al.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.

[77]  Yili Yang,et al.  Expression and evaluation of RING finger proteins. , 2005, Methods in enzymology.

[78]  David Komander,et al.  High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site , 2002, The EMBO journal.